Interações medicamentosas
Arformoterol + Indacaterol-glycopyrronium
Gravidade: Grave
Arformoterol and Indacaterol-glycopyrronium: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Both agents are inhaled long-acting beta-2 agonists (indacaterol is one component of the combination), so using them together duplicates therapy and adds to beta-adrenergic cardiovascular effects. This can cause tachycardia, hypokalemia, QTc prolongation and arrhythmia.
O que esta interação significa em palavras simples
Arformoterol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Arformoterol belongs to Respiratory; Indacaterol-glycopyrronium belongs to Respiratory.
Por que acontece
Additive beta-2 adrenergic stimulation leading to hypokalemia, tachycardia and QT prolongation.
O que fazer
Avoid concurrent use of two long-acting beta-agonists and keep a single LABA-containing regimen. If a switch is made, stop one agent and monitor heart rate, potassium and ECG as indicated.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Arformoterol e Indacaterol-glycopyrronium, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Indacaterol-glycopyrronium
Outras interações de Arformoterol
Perguntas frequentes
Can I take Arformoterol with Indacaterol-glycopyrronium?
MediHelp rates the interaction as major. Arformoterol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents are inhaled long-acting beta-2 agonists (indacaterol is one component of the combination), so using them together duplicates therapy and adds to beta-adrenergic cardiovascular effects. This can cause tachycardia, hypokalemia, QTc prolongation and arrhythmia.
How serious is the interaction between Arformoterol and Indacaterol-glycopyrronium?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use of two long-acting beta-agonists and keep a single LABA-containing regimen. If a switch is made, stop one agent and monitor heart rate, potassium and ECG as indicated.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arsenic trioxide, Betaxolol. The full list is on the Indacaterol-glycopyrronium page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
